Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
Clinical trial NCT02525094 · COMPLETED
Trial details
- NCT number
- NCT02525094
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-15
- Primary completion
- 2016-05-09
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.